Melatonin Orifarm

Melatonin, the active ingredient in Melatonin Orifarm, is a melatonin receptor agonist presented as an oral tablet for oral use. It treats insomnia and sleep‑wake rhythm disorders in adults. GNH USA supplies Melatonin Orifarm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Melatonin Orifarm acts on the melatonin MT1 and MT2 receptors to regulate circadian rhythm and support sleep. - Insomnia: helps reduce sleep onset latency and improve sleep maintenance in adults. - Sleep‑wake rhythm disorders: assists in normalising disrupted sleep‑wake cycles such as delayed sleep phase syndrome. - Jet lag: aids adjustment of the internal clock after rapid east‑west travel, promoting faster sleep onset at the new destination.

Melatonin Orifarm may cause adverse reactions, most of which are mild and transient.

Common Side Effects: - Drowsiness or daytime sleepiness - Headache - Dizziness - Nausea or mild gastrointestinal discomfort - Vivid dreams or nightmares - Mild abdominal cramps

Serious or Rare Side Effects: - Allergic reactions such as rash, itching, or angioedema - Severe dizziness or vertigo - Mood changes including depression or hallucinations - Abnormal heart rhythm or palpitations - Severe gastrointestinal upset or vomiting - Rare cases of seizures in predisposed individuals

When considering Melatonin Orifarm, several safety measures should be observed. - Assess underlying sleep disorder: confirm diagnosis before use. - Avoid concurrent alcohol consumption: may increase sedation. - Monitor patients with depression: melatonin can affect mood. - Use caution in hepatic impairment: metabolism may be altered. - Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Melatonin Orifarm can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Concurrent use with CNS depressants (e.g., benzodiazepines, barbiturates): increased sedation risk. - Interaction with anticoagulants (e.g., warfarin): potential for enhanced bleeding. - Co‑administration with immunosuppressants (e.g., cyclosporine): possible alteration of drug levels.

Moderate Interactions (Monitor Closely): - Combination with caffeine or other stimulants: may reduce melatonin efficacy. - Use with oral contraceptives: possible reduction in contraceptive effectiveness. - Interaction with antihypertensives: may cause additive blood‑pressure lowering.